Ophthalmology · New York, NY
NPI
1841451937
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
140 E 80th St
New York, NY, 10075
Phone (212) 772-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.0M
109,611 services
Medicare patients, 2024
1,350
Average age 76
Drug cost, 2024
$333K
879 prescriptions
Company payments, 2025
$35K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward I Marcus was code J2403 (chloroprocaine hcl ophthalmic, 3% gel, 1 mg), 58,400 times for 56 patients. In total Edward I Marcus billed 109,611 services in 49 codes, and Medicare paid $5.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 58,400 | 56 | $0.47 | $27K |
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 25,868 | 102 | $27.14 | $702K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 5,420 | 69 | $86.23 | $467K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,764 | 1,324 | $33.64 | $127K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 3,720 | 131 | $258.35 | $961K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 3,586 | 56 | $116.06 | $416K |
| 67028 Intravitreal Injection | Office | 2,056 | 546 | $109.62 | $225K |
| J0178 Injection, aflibercept, 1 mg | Office | 978 | 155 | $633.50 | $620K |
| 67210 Eye | Office | 900 | 329 | $440.58 | $397K |
| 92235 Angiography | Office | 817 | 594 | $144.60 | $118K |
| 92012 Ophthalmological E&M | Office | 811 | 630 | $73.64 | $60K |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 742 | 35 | $159.55 | $118K |
| 92014 Ophthalmological E&M | Office | 480 | 414 | $102.07 | $49K |
| 67210 Eye | Facility | 206 | 95 | $435.30 | $90K |
| J9035 Injection, bevacizumab, 10 mg | Office | 200 | 68 | $52.94 | $11K |
By year: 2022 $3.4M for 17,149 services; 2023 $4.0M for 33,167 services; 2024 $5.0M for 109,611 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward I Marcus prescribed most often to Medicare patients was Prednisolone Acetate, with 154 prescriptions and refills. In total Edward I Marcus wrote 879 Medicare prescriptions that cost $333K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 154 | 195 | 110 | $7,584 |
| Ofloxacin Generic | 124 | 138 | 107 | $2,107 |
| Atropine Sulfate Generic | 123 | 148 | 100 | $5,917 |
| Dorzolamide Hcl Generic | 90 | 160 | 38 | $1,280 |
| Latanoprost Generic | 77 | 155 | 29 | $845 |
| Brimonidine Tartrate Generic | 41 | 95 | 18 | $4,516 |
| Bromfenac Sodium Generic | 35 | 37 | Under 11 | $6,186 |
| Timolol Maleate Generic | 28 | 53 | Under 11 | $781 |
| Restasis Cyclosporine | 22 | 64 | Under 11 | $34K |
| Difluprednate Generic | 17 | 19 | Under 11 | $2,053 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 15 | 35 | Under 11 | $414 |
| Lumigan Bimatoprost | 15 | 20 | Under 11 | $5,099 |
| Alphagan P Brimonidine Tartrate | 11 | 18 | Under 11 | $3,495 |
Brand drugs: 304 claims; generic drugs: 575 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward I Marcus $35K ($35K in general payments such as food, travel and fees) from 16 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 32 | $16K |
| Astellas Pharma US Inc 4503.T | 22 | $10K |
| Apellis Pharmaceuticals, Inc. APLS | 15 | $2,453 |
| ANI Pharmaceuticals, Inc. ANIP | 26 | $2,287 |
| Harrow Eye, LLC | 34 | $1,879 |
| Bausch & Lomb Americas Inc. BLCO | 22 | $682 |
| Mallinckrodt Hospital Products Inc. | 19 | $458 |
| Abbvie Inc. ABBV | 25 | $391 |
| Genentech USA, Inc. ROG.SW | 13 | $269 |
| Alcon Vision LLC ALC | 2 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.